Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Nature's Sunshine Products Inc. (NATR:NASDAQ), powered by AI.
Nature's Sunshine Products Inc. is currently trading at $20.08. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Nature's Sunshine Products Inc. on Alpha Lenz.
View Nature's Sunshine Products Inc.'s valuation metrics on Alpha Lenz.
“Nature's Sunshine Products Inc.'s ROE is 12.3%. Explore profitability and growth together.”
Ask for details →Nature's Sunshine Products Inc. is a well-established player in the health and wellness sector, primarily known for its production and distribution of high-quality dietary supplements and nutritional products. The company's extensive product line includes vitamins, minerals, herbal supplements, and personal care items designed to support a healthy lifestyle. Catering to a diverse customer base, Nature's Sunshine Products operates through direct selling, utilizing a network of independent distributors and a robust online presence to reach consumers globally. Founded in 1972 and headquartered in Lehi, Utah, the company has a strong commitment to natural health and sustainability, emphasizing rigorous quality assurance processes to ensure product efficacy and safety. Its role in the financial market is significant as it contributes to the ever-growing demand for wellness products, driven by increasing consumer health awareness and preference for natural health solutions. By continuously expanding its offerings and entering new markets, Nature's Sunshine Products Inc. remains a key player in driving industry standards and meeting the needs of health-conscious individuals worldwide.
“Nature's Sunshine Products Inc.'s ROE is 12.3%. Explore profitability and growth together.”
Ask for details →Nature's Sunshine Products Inc. (ticker: NATR) is a company listed on NASDAQ in the Consumer Defensive sector (Packaged Foods). It has approximately 819 employees.
The current price is $20.08 with a P/E ratio of -x and P/B of -x.
ROE is 12.32% and operating margin is 5.15%. Annual revenue is $480M.